1
|
Kulkarni D, Sherkar R, Shirsathe C, Sonwane R, Varpe N, Shelke S, More MP, Pardeshi SR, Dhaneshwar G, Junnuthula V, Dyawanapelly S. Biofabrication of nanoparticles: sources, synthesis, and biomedical applications. Front Bioeng Biotechnol 2023; 11:1159193. [PMID: 37200842 PMCID: PMC10185809 DOI: 10.3389/fbioe.2023.1159193] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2023] [Accepted: 04/10/2023] [Indexed: 05/20/2023] Open
Abstract
Nanotechnology is an emerging applied science delivering crucial human interventions. Biogenic nanoparticles produced from natural sources have received attraction in recent times due to their positive attributes in both health and the environment. It is possible to produce nanoparticles using various microorganisms, plants, and marine sources. The bioreduction mechanism is generally employed for intra/extracellular synthesis of biogenic nanoparticles. Various biogenic sources have tremendous bioreduction potential, and capping agents impart stability. The obtained nanoparticles are typically characterized by conventional physical and chemical analysis techniques. Various process parameters, such as sources, ions, and temperature incubation periods, affect the production process. Unit operations such as filtration, purification, and drying play a role in the scale-up setup. Biogenic nanoparticles have extensive biomedical and healthcare applications. In this review, we summarized various sources, synthetic processes, and biomedical applications of metal nanoparticles produced by biogenic synthesis. We highlighted some of the patented inventions and their applications. The applications range from drug delivery to biosensing in various therapeutics and diagnostics. Although biogenic nanoparticles appear to be superior to their counterparts, the molecular mechanism degradation pathways, kinetics, and biodistribution are often missing in the published literature, and scientists should focus more on these aspects to move them from the bench side to clinics.
Collapse
Affiliation(s)
- Deepak Kulkarni
- Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India
- *Correspondence: Vijayabhaskarreddy Junnuthula, , ;Deepak Kulkarni, ; Sathish Dyawanapelly,
| | - Rushikesh Sherkar
- Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India
| | - Chaitali Shirsathe
- Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India
| | - Rushikesh Sonwane
- Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India
| | - Nikita Varpe
- Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India
| | - Santosh Shelke
- Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India
| | - Mahesh P. More
- Department of Pharmaceutics, Dr Rajendra Gode College of Pharmacy, Malkapur, Buldana, India
| | - Sagar R. Pardeshi
- Department of Pharmaceutics, St John Institute of Pharmacy and Research, Palghar, India
| | | | - Vijayabhaskarreddy Junnuthula
- Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland
- *Correspondence: Vijayabhaskarreddy Junnuthula, , ;Deepak Kulkarni, ; Sathish Dyawanapelly,
| | - Sathish Dyawanapelly
- Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India
- *Correspondence: Vijayabhaskarreddy Junnuthula, , ;Deepak Kulkarni, ; Sathish Dyawanapelly,
| |
Collapse
|